These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 34963449)
1. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo. Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449 [TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of nano-PTX to the brain tumor-associated macrophages. Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254 [TBL] [Abstract][Full Text] [Related]
3. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641 [TBL] [Abstract][Full Text] [Related]
4. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles. Lv L; Jiang Y; Liu X; Wang B; Lv W; Zhao Y; Shi H; Hu Q; Xin H; Xu Q; Gu Z Mol Pharm; 2016 Oct; 13(10):3506-3517. PubMed ID: 27636161 [TBL] [Abstract][Full Text] [Related]
6. Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery. Guan J; Zhang Z; Hu X; Yang Y; Chai Z; Liu X; Liu J; Gao B; Lu W; Qian J; Zhan C Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28841776 [TBL] [Abstract][Full Text] [Related]
7. All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide. Ran D; Zhou J; Chai Z; Li J; Xie C; Mao J; Lu L; Zhang Y; Wu S; Zhan C; Lu W Theranostics; 2020; 10(9):4073-4087. PubMed ID: 32226540 [TBL] [Abstract][Full Text] [Related]
8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
9. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery. Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703 [TBL] [Abstract][Full Text] [Related]
11. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy. Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518 [TBL] [Abstract][Full Text] [Related]
12. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting. Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223 [TBL] [Abstract][Full Text] [Related]
13. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel. Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815 [TBL] [Abstract][Full Text] [Related]
15. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex. Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351 [TBL] [Abstract][Full Text] [Related]
17. Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles. Zheng J; Wan Y; Elhissi A; Zhang Z; Sun X Pharm Res; 2014 Aug; 31(8):2220-33. PubMed ID: 24595496 [TBL] [Abstract][Full Text] [Related]
18. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390 [TBL] [Abstract][Full Text] [Related]
19. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
20. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]